Nitrase Therapeutics
Grace Pohan is a Senior Research Associate in Assay Development at Nitrase Therapeutics since April 2023. Previous experience includes serving as an Assistant Specialist at the University of California, San Francisco, where expertise in cell-based high throughput screening, automation, and image segmentation was developed from September 2019 to January 2022. Grace worked as a Research Associate and as a Master of Applied Science Candidate in Chemical Engineering at the University of Waterloo, with a focus on hydrogel vascular graft fabrication and endothelial cell culture. Prior to that, Grace was a Manufacturing Engineer II at Baxter BioScience Manufacturing SARL, specializing in upstream manufacturing and bioreactor operations. Academic foundations include a Master’s Degree in Chemical Engineering from the University of Waterloo and a Bachelor of Engineering in Bioengineering from the National University of Singapore.
This person is not in any teams
This person is not in any offices
Nitrase Therapeutics
1 followers
Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes that it discovered, to develop a pipeline of therapies against a broad variety of diseases. The medicines that Nitrase Therapeutics is developing will target these enzymes and potentially help slow or halt the progression of a wide variety of diseases in which nitrases and nitro-substrates play a role, including Parkinson’s and cancer. Nitrase Therapeutics (under the former name Nitrome Biosciences) has been widely recognized and has won multiple awards including the prestigious Target Advancement grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).